Literature DB >> 14666019

The dynamic air bubble trap reduces cerebral microembolism during cardiopulmonary bypass.

M Schoenburg1, B Kraus, A Muehling, U Taborski, H Hofmann, G Erhardt, S Hein, M Roth, P R Vogt, G F Karliczek, W-P Kloevekorn.   

Abstract

OBJECTIVE: Neuropsychologic disorders are common after coronary artery bypass operations. Air microbubbles are identified as a contributing factor. A dynamic bubble trap might reduce the number of gaseous microemboli.
METHODS: A total of 50 patients undergoing coronary artery bypass operation were recruited for this study. In 26 patients a dynamic bubble trap was placed between the arterial filter and the aortic cannula (group 1), and in 24 patients a placebo dynamic bubble trap was used (group 2). The number of high-intensity transient signals within the proximal middle cerebral artery was continuously measured on both sides during bypass, which was separated into 4 periods: phase 1, start of bypass until aortic clamping; phase 2, aortic clamping until rewarming; phase 3, rewarming until clamp removal; and phase 4, clamp removal until end of bypass. S100 beta values were measured before, immediately after, and 6 and 48 hours after the operation and before hospital discharge.
RESULTS: The bubble elimination rate during bypass was 77% in group 1 and 28% in group 2 (P <.0001). The number of high-intensity signals was lower in group 1 during phase 1 (5.8 +/- 7.3 vs 16 +/- 15.4, P <.05 vs group 2) and phase 2 (6.9 +/- 7.3 vs 24.2 +/- 27.3, P <.05 vs group 2) but not during phases 3 and 4. Serum S100 beta values were equally increased in both groups immediately after the operation. Group 2 patients had higher S100 beta values 6 hours after the operation and significantly higher S100 beta values 48 hours after the operation (0.06 +/- 0.14 vs 0.18 +/- 0.24, P =.0133 vs group 2). Age and S100 beta values were correlated in group 2 but not in group 1.
CONCLUSION: Gaseous microemboli can be removed with a dynamic bubble trap. Subclinical cerebral injury detectable by increases of S100 beta disappears earlier after surgical intervention.

Entities:  

Mesh:

Year:  2003        PMID: 14666019     DOI: 10.1016/s0022-5223(03)00603-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  [Cognitive deterioration after cardiosurgery].

Authors:  N Schwarz; M Schönburg; S Kastaun; T Gerriets; M Kaps
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

2.  Preventing gaseous microemboli during blood sampling and drug administration: an in vitro investigation.

Authors:  Gerard J Myers
Journal:  J Extra Corpor Technol       Date:  2007-09

3.  Pulsatile flow decreases gaseous micro-bubble filtering properties of oxygenators without integrated arterial filters during cardiopulmonary bypass.

Authors:  Aldo D Milano; Mikhail Dodonov; Francesco Onorati; Tiziano Menon; Leonardo Gottin; Giovanni Malerba; Alessandro Mazzucco; Giuseppe Faggian
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-09

Review 4.  S100 and S100β: biomarkers of cerebral damage in cardiac surgery with or without the use of cardiopulmonary bypass.

Authors:  Shi-Min Yuan
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

5.  Serum S-100β and NSE levels after off-pump versus on-pump coronary artery bypass graft surgery.

Authors:  Lei Zheng; Qing-Ming Fan; Zhen-Yu Wei
Journal:  BMC Cardiovasc Disord       Date:  2015-07-16       Impact factor: 2.298

6.  Neuroprotective effects of dynamic bubble trap use in patients undergoing pulmonary endarterectomy: a two-arm randomized controlled trial.

Authors:  Stefan Guth; Martin Juenemann; Jasmin El Shazly; Tibo Gerriets; Juergen Hennig; Marius Butz; Sabrina Kastaun; Christoph B Wiedenroth; Markus Schoenburg; Marc Wollenschlaeger; Georg Bachmann
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

Review 7.  Neuroprotection against stroke and encephalopathy after cardiac surgery.

Authors:  Daniel G Jovin; Karl G Katlaps; Ben K Ellis; Benita Dharmaraj
Journal:  Interv Med Appl Sci       Date:  2019-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.